Journal
ONCOIMMUNOLOGY
Volume 2, Issue 7, Pages -Publisher
LANDES BIOSCIENCE
DOI: 10.4161/onci.24658
Keywords
aspirin; cyclooxygenase 1; dendritic cell; MYCN; myeloid-derived suppressor cell; neuroblastoma; prostaglandin D-2; thromboxane A(2); tumor-associated macrophage
Categories
Ask authors/readers for more resources
The daily intake of low-dose aspirin lowers the risk of several cancers among the adults. The continuous administration of low-dose aspirin to TH-MYCN mice (a model of pediatric neuroblastoma) delays tumor outgrowth and decreases tumor-promoting inflammation by inhibiting regulatory cells of the innate immune system as well as immunosuppressive mediators such as transforming growth factor (TGF) and thromboxane A(2). These findings pave novel avenues for the clinical management of neuroblastoma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available